[LCID Study Number: 2017-059]
NRG-LU002- Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
This study is comparing any good and bad effects of using the usual drug therapy plus radiation to treat lung cancer and areas of metastasis (where the cancer has spread) compared with the usual drug therapy alone. Two types of radiation delivery will be used in this study. One type is called stereotactic body radiation therapy (SBRT) and will be used to treat areas of metastasis. The second type is standard radiation therapy and may be used to treat your primary lung tumor if SBRT cannot be used.
Primary Contact Email: [email protected]
Primary Contact Phone: 781-744-3071